Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: To all interested, just my two cents.

All true....but factor the possibility of a defined business strategy of dividends into the share price. If PTSC should win there should be a foreseeable stream of licenses for a few years to come.

50 cents a share for a stock issuing quarterly dividends seems a bit low.

teremoto

16
Sep 30, 2013 03:39PM
11
Sep 30, 2013 03:54PM
11
Sep 30, 2013 04:08PM
12
Sep 30, 2013 04:20PM
19
Sep 30, 2013 04:51PM
5
Sep 30, 2013 05:04PM
6
Sep 30, 2013 05:30PM
2
Sep 30, 2013 05:43PM
11
Sep 30, 2013 05:52PM
1
Sep 30, 2013 07:59PM
Share
New Message
Please login to post a reply